Nektar Therapeutics
NKTR
#4891
Rank
โ‚น181.00 B
Marketcap
โ‚น5,357
Share price
-0.69%
Change (1 day)
611.59%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -โ‚น886.46

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น971.83. In 2024 the company made an earnings per share (EPS) of -โ‚น844.16 an increase over its 2023 EPS that were of -โ‚น2,087.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น886.465.01%
2024-โ‚น844.16-59.54%
2023-โ‚น2,087-25.89%
2022-โ‚น2,815-31.12%
2021-โ‚น4,08714.86%
2020-โ‚น3,559-1.19%
2019-โ‚น3,601-163.96%
2018โ‚น5,631-725.4%
2017-โ‚น900.37-42.73%
2016-โ‚น1,57283.33%
2015-โ‚น857.5039.53%
2014-โ‚น614.54-69.29%
2013-โ‚น2,001-6.67%
2012-โ‚น2,144

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น832.38-185.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น124.81-112.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,380-241.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น202.94-79.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น338.94-134.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น662.18-168.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚น6.67-100.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น88.61-109.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland